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Abstract
Since its introduction into the Integrated Pest Management (IPM) program over 20 years ago, the
biotechnological approach for insect pest management, starting with transgenic Bacillus
thuringiensis (Bt), appeared to have revolutionized the concept of genetic manipulation approach
in insect pest management and crop protection. Transgenic (Bt) crops have offered great benefits
in insect management for crop protection but soon after its implementation, the technology
started facing the major issue of insect resistance, leading researchers to start pursuing
advancements in newer biotechnological approaches to insect pest management, such as Gene
Editing (the RNA interference (RNAi); Gene Drives and most recently CRISPR-Cas9 system).
By 2012, scientists found a way to use CRISPR-Cas as a genome editing tool and in 2013 the
CRISPR-Cas application in plants was successfully achieved, in the lab; leading to new
opportunities for researchers to continue studying the CRISPR-Cas system for its potential
applications and the opportunity to gain a better understanding of RNA mediated cell functions
(given that RNA holds a central role in almost everything a cell does). This review will discuss
the potential uses of CRISPR-Cas9 systems for agricultural and medical insect pest management
as well its applications for plant diseases/crop protection. The review will also discuss the
limitations, potential issues and prospects of the CRISPR-Cas9 technology as it pertains to insect
pest management.
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I. Introduction
Insect pest management has been an ongoing battle for Entomologists, Farmers and Agricultural
industries, with control strategies continuously evolving and becoming perhaps more effective.
Control approaches have evolved throughout the years, starting with humans hand-picking and
killing the insects to cultural and biological control approaches and to the discovery and wide
spread use of chemical insecticides by mid -1940s, which revolutionized the Agricultural
industries in the 1950s and early 1960s. Chemical control demonstrated the kind of effectiveness
that had not been seen before and continued to be widely used. The public became increasingly
reliant on its use as it increased our food production and removed insects that carried diseases.
Such overuse had ultimately led to what was termed “Chemical crisis,” where higher and higher
doses of chemicals became necessary as insects became resistant to the chemicals (“History of
IPM” n.d.), until Rachel Carson brought public awareness of the environmental effects of
chemical pesticides in her book, “Silent Spring,” published in 1962 (Unsworth 2010). The
growing knowledge about the negative side-effects associated with excessive use of chemical
pesticides had led to shifting focus to a newer, more comprehensive pest management approach,
the Integrated Pest Management (IPM). The term Integrated Pest Management was first used in
Agriculture beginning in the 1970s (“History of IPM” n.d.). IPM is essentially a pest
management strategy that uses comprehensive approaches to reduce pest status to tolerable levels
while minimizing the environmental effects (Alston 2011).
Since its development, the concept of Integrated Pest Management (IPM) has been strategically
implemented, and remains arguably the “best” known form of insect pest management according
to many. However, IPM has its own limitations. Most of the limitations of IPM come from
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identifying the best tactics to implement in a given management strategy. These limitations have
led to continuous research and the development of biotechnological approaches for insect pest
management. In this review I will be exploring the new biotechnological approaches to insect
pest management and crop protection, including transgenic Bt and gene editing approaches with
more focus on the emerging CRISPR-Cas9 mediated gene editing technology. I’ll explore the
concept, the mechanisms and the applications of the CRISPR-Cas9 gene editing technology as
well as the limitations, potential issues and future prospects of the technology.

II. Transgenic Bacillus thuringiensis (Bt) Crop Approach
Transgenic Bt crops are genetically engineered from spore forming bacterium (Bacillus
thuringiensis (Bt)) that produces crystal-like proteins (Cry proteins). Cry proteins are toxic to
many species of insects, including insects that are pests of corn, with high effectiveness in
controlling the caterpillars of Lepidoptera and Coleoptera insects. The crystal toxins work by
binding to specific receptors in the mid-gut of the target caterpillars, after being ingested, and
create perforations in the lining of the insect’s gut, leading to the insect’s death. This approach is
known to have no effects on humans or other vertebrates (vertebrates do not have receptors for
the crystal-toxins to bind to).
Transgenic Bt crop technology has provided many benefits to farmers, Agricultural/seed
companies and to the consumers, which has led to fewer uses of insecticides, increased yield and
cheaper food prices. Corn production, for example, has greatly benefited from the use of
transgenic Bt to control most major pests of corn including European corn borer (Lepidoptera:
Crambidae), Western corn rootworm (Coleoptera: Chrysomelidae), Fall armyworm Lepidoptera:
Noctuidae), and Corn Earworm (Lepidoptera: Noctuidae).
6

One type of transgenic Bt-corn expressing the Cry1Ab protein provides protection against certain
Lepidopteran pests, mainly the European corn borer. For instance, prior to the use of Cry1Ab
protein, European corn borer was one of the most damaging insect pests in north America,
resulting in estimated damages and control costs exceeding $1 Billion each year. The larvae feed
on leaves and tunnel into the stalk, ear shanks and ear (Ostlie et al. 1997; Rice et al. 1997).
Transgenic Bt control of the European corn borer offered dramatically superior control compared
to the IPM options that were available. In earlier field tests against natural and added European
corn borer infestations, the Bt-corn showed a more than 99% control of first generation European
corn borer larvae in young (whorl-stage) corn plants compared to the chemical insecticide
treatments, which typically provide 60-95% control of first generation European corn borer
larvae (Ostlie et al. 1997).
The Western corn rootworm is also among the most serious pests of corn in the United States of
America (Vaughn et al. 2005). Western corn rootworm larvae feed on the root tissue, weakening
the root system leading to lower yield. The IPM options of chemical insecticides and crop
rotations had been the only two options available to growers prior to the development of the
transgenic Bt approach. Cry3Bb1(Bt) crystal toxin variant was created to target the Western corn
rootworm larvae, resulting in significantly improved control of the Western corn rootworm.
Transgenic approach has also provided control of insect pests that are generally difficult to
manage with synthetic insecticides. One example is the management of Fall armyworm, which is
an important pest of cotton and maize. In maize, Fall armyworm can cause major defoliation
damages from feeding on the early stage leaf and on the ear, causing ear injury as the corn plants
reach later stages of development. Before transgenic Bt approach, previous methods used to
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manage Fall armyworm in maize and cotton were not very efficient. The spatial distribution and
concealed locations of Fall armyworm eggs and small larvae in maize and cotton can make
detection and control with foliar insecticides difficult (Siebert et al. 2008). Maize hybrids and
cotton varieties expressing Cry1F (Bt trait) have demonstrated economical levels of efficacy
against Fall armyworm in field and laboratory studies, according to evaluations by Siebert et al.
(2008).
Transgenic Bt approach has been widely used in the last 20+ years as an effective
biotechnological method of insect pest management, especially in the field of Agriculture. It has
provided significant environmental and economic benefits. But the sustainable use of the
transgenic Bt technology is being threatened by the rapid evolution of insect resistance to Bt
traits (Carrier et al. 2017).
Transgenic Bt Resistance
Insects evolving resistance to Bt crops has been one of the biggest challenges the transgenic Bt
approach has faced. Since the first detection of field-evolved insect resistance to Bt crops,
starting in the early 2000s, large parts of the Agricultural biotech research have been focused on
resistance management with the objectives of finding ways to halt the progression of resistance
or finding other approaches that can potentially replace or aid the transgenic approach.
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Table 1. Seven cases of field-evolved practical resistance to single-toxin Bt crops (Carrière et al.
2016)
Insect

Helicoverpa zea

Bt crop

Bt Toxin

Country

Years of

Year of initial

Durability

detection

Cotton

Cry1Ac

USA

6

2002

Corn

Cry1Ab

South Africa

6

2004

Corn

Cry1Fa

USA

3

2006

Cotton

Cry1Ac

India

6

2008

Corn

Cry3Bb

USA

6

2009

Corn

mCry3A

USA

4

2011

Corn

Cry1Fa

Brazil

2

2011

(Corn Earworm)
Busseola fusca

(African Maize Stalkborer)
Spodoptera frugiperda

(Fall Armyworm)
Pectinophora gossypiella

(Pink bollworm)
Diabrotica v. virgifera

(Western corn rootworm)
Diabrotica v. virgifera

(Western corn rootworm)
Spodoptera frugiperda

(Fall Armyworm)
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Since the first detection of field-evolved insect resistance to Bt traits, several resistance
management strategies have been identified, but the “Refuge” strategy and the theory of stacks
(Pyramided) have been the two most used resistance management strategies. “Refuge” is non‐Bt
host plants or an area of the same crop that does not contain the Bt traits. The concept of the
Refuge strategy is to reduce heritability of resistance genes by providing refuge that produces
susceptible adults and promotes mating between resistant and susceptible adults to decrease the
dominance of resistance (Tabashnik et al. 2004). The refuge area serves as a source of wild-type
(non-mutant) insects. To implement the Refuge strategy, farmers must plant refuges of non‐Bt
host plants near the Bt crops, expecting that the resistant adults emerging from Bt crops will mate
with susceptible adults emerging from the refuge plants to produce non-resistant offspring (Fig.
1.) and therefore delaying the development of resistance. This is dictated by the law of genetics
(“Bacillus thuringiensis” n.d.).

Fig 1: Concept of Refuge Strategy. Image Source: University of California San Diego.

The Environmental Protection Agency (EPA), in the United States, requires the farmers to plant
at least 20% of refuge area within their corn acres (“Bacillus thuringiensis” n.d). The Refuge
strategy has shown success in delaying resistance to Bt crops; however, this is mostly in pests
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with already high susceptibility to Bt toxins. In order to sustain the efficacy of Refuge strategy
against pests with lower susceptibility to Bt toxins, larger refuges are needed and Bt crops must
be integrated with other pest management tactics (Carrière et al. 2016).
In pyramided theory, transgenic plants are engineered to carry and express two or more different
types of Bt crystal toxins effective against the same target insect pest. This model suggested that
since there are at least two modes of action, plants expressing two or more different Bt toxins
genes have the potential to delay resistance more effectively than plants expressing a single-toxin
(Zhao et al. 2003). One of the earlier case studies to test these predictions included a greenhouse
study by Zhao et al. (2003) using transgenic Bt broccoli plants and an artificial population of
Diamondback moths, Plutella xylostella (Lepidoptera: Plutellidae), carrying genes for resistance
to the Bt toxins (Cry1Ac and Cry1C). After 24 generations of selection, resistance in pyramided
(two-gene) plants was significantly delayed as compared with resistance to single-gene plants.
Following were many other lab studies confirming delayed resistance in pyramided crops.
Though many controlled studies have proven the effectiveness of the pyramided plants and the
approach has been widely used to delay evolution of pest resistance, the field performances have
not consistently offered the desirable level of resistance management. Cross-resistance and
antagonism between toxins used in pyramids are common (Carrière et al. 2015) and has been
suggested to constitute, in part, some of the contributing factors for the limited field
performances of the pyramids.
Another used resistance management strategy (often used in conjunction with the Refuge and the
Pyramided strategy) is the “Seed Mixture,” also known as “Refuge in the Bag.” The “Seed
Mixture” approach is when the seeds of Bt plants and the seeds of non-Bt plants are randomly
11

mixed in a bag of seeds and planted within a field side-by-side. One of the benefits of this
approach is to help enforce farmers’ compliance with the Refuge strategy.
While the Refuge and Pyramided approaches have shown some degree of success in managing
evolved resistance, the insect resistance to transgenic Bt has not been completely resolved and
has continued to spread. Consequently, newer biotechnological approaches are needed and are
being pursued to potentially replace or be used in conjunction with the transgenic Bt approach
for a more effective insect pest management, especially in the field of Agriculture – this is where
the emerging new biotechnology like gene editing can play a major role.

III. Gene Editing Approach – RNAi; CRISPR- Cas9 Gene Drive system
Insects developing resistance to the Bt trait is an issue that has been threatening the Agricultural
biotech industry, leading to biotech companies tirelessly working to identify new, cost effective
and environmentally sound approaches to insect pest management, or approaches to overcome
the issue of insect resistance. Gene editing has become the newer, lead technology in the biotech
industries in identifying newer biotechnological approaches to insect pest management. Gene
editing, also known as genome editing technology, basically takes advantage of the cell’s own
natural mechanisms to effectively alter the function of a gene. Genome editing is an approach in
which a specific target DNA sequence of the genome is altered by adding, removing, or
replacing DNA bases (Bortesi and Fischer 2014).
RNA interference (RNAi) Approach
In the past years, the RNA interference (RNAi) gene editing approach for gene silencing has
been extensively researched and incorporated into the pest management and crop protection
12

programs. RNA interference is a gene silencing phenomenon that involves introducing a doublestranded RNA (dsRNA) into a cell to result in suppression of undesired genes and in specific
cases desired, novel genes to be expressed (Kamthan et al. 2015).
The hopes for the RNAi approach were to be able to control a wider range of insects, especially
the sap-sucking insects, which transgenic crops have not been able to control. Transgenic Bt
toxins are limited to acting only in the mid-gut of susceptible target insects, mostly in
Lepidoptera and Coleoptera larvae, leaving other insect orders unmanaged.
The concept of RNAi approach for insect control is for the insect to uptake the double-stranded
RNA (dsRNA) into its system thorough feeding on plants expressing the dsRNA hairpin or
through other means; with the expectation for the dsRNA to spread throughout all the cells in the
body of the target insects. But achieving this effect is highly dependent on the delivery methods,
as gene silencing is only limited to the cells that are affected (Katoch et al. 2013). Various
delivery methods have been studied in different groups of organisms; these delivery methods
include injection method, feeding, soaking, and transgenic plants expressing dsRNA (Katoch et
al. 2013). The Injection method involves direct injection of dsRNA into target tissues – this
method was found to be delicate and time consuming. Feeding/ingestion method involves uptake
of dsRNA through insects feeding on transgenic plants expressing hairpin RNA – but the
efficiency of RNAi by ingestion of dsRNA varies between different species. Also, after oral
delivery, it’s hard to determine the amount of dsRNA taken in by the insect, and in addition, it
requires a greater amount of material for delivery (Surakasi 2011as cited in Katoch et al. 2013;
Chen et al. 2010 as cited in Katoch et al. 2013). The soaking method involves soaking the
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organism (insect) in a dsRNA solution; however, the method is suitable only for specific insects
and of developmental stages that readily absorb dsRNA from the solution (Katoch et al. 2013).
RNAi technology has been shown to be successful in different insect orders in knockdown of
target genes, including successful effects on Diabrotica v. virgifera, corn rootworm larvae.
However, the technology is still being researched with current limitations, making it less
sustainable as an effective approach for insect pest management.
Gene Drive Approach
Gene Drive refers to gene editing technology that enhance the probability that a specific gene
will be inherited by an organism’s offspring by bias inheritance (Lei et al. 2016). When an
organism is engineered, the alterations made almost always harm its ability to reproduce in the
wild. But if the same change is embedded within a gene drive, the inheritance advantage
conferred by the drive seem to counterbalance the harmful effects (Esvelt n.d.). The idea of Gene
Drives was inspired by the behavior of a class of natural genes, termed selfish genetic element,
also known as “selfish genes.” Selfish genes are genetic segments that can enhance and promote
their own inheritability into the next generation (McFarlane et al. 2018), even if they do not
confer any advantages to the organism. Gene Drive technology is essentially the use of
engineered selfish genes that uses site-specific endonucleases to spread traits into populations
(Hammond et al. 2016), thus Gene Drive can spread a particular gene throughout a population of
the same species.
The Gene Drive approach has been identified as a potential new biotechnological strategy to
insect pest management, especially for disease vectoring insects and potentially for Agricultural
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insects and other invasive insect species. Gene Drives only affect sexually reproducing
organisms, making it a suitable technology for managing/eliminating disease
carrying/transmitting insects. The approach could also be used to potentially delete the
resistance genes in insects, therefore resolving the issue of insect resistance (to the transgenic Bt
or to insecticides).
Gene Drive technology works by tricking the rules of natural inheritance – under the law of
natural inheritance (Mendelian inheritance), all sexually-reproducing organisms will inherit 50%
of their genetic makeup from each of their parents. This means a particular gene only has 50%
chance of being transmitted from a parent to the offspring. Gene Drive technology interferes
with this process to find the wild-type version of the targeted gene and replacing it with the
desired/altered gene (the Gene Drive), ensuring that more than half of the offspring will inherit
the desired gene.
Gene Drive modification is achieved by attaching Gene Drives to a chosen/altered gene and
delivering into an organism’s genome. Thus, when an organism carrying the Gene Drive goes
and mates with the wild-type organism, the wild-type version of the gene that would have been
inherited from the wild-type parent will get identified and molecularly cut out (cleaved). Then
the cell will repair the damage by copying the altered version of the gene (the Gene Drive) used
as a template to patch up the damaged cell. The organism will now have two copies of the same
gene (one in each chromosome) to pass on to the next generation. This same process will be
repeated with each generation, resulting in the altered gene spreading through the population
(“What's a Gene Drive?” 2015).
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Fig. 2. Gene Drive Concept. Image source: E. Otwell and M. Telfer.

Unfortunately, Gene Drive technology on its own, without the CRISPR-Cas9 system, is not as
effective and vice versa. Gene Drive and CRISPR-Cas9 are basically two separate technologies
with the same objective, which is making gene alterations using gene editing technology to
create populations of organisms that carry a desired/altered gene. CRISPR-Cas9 technology
allows scientists to make precise changes (gene alteration) to DNA, in the lab. Gene Drive
technology allows scientists to push those changes through a wild-type population (“The bold
plan to end malaria with a gene drive” 2018).
Prior to CRISPR-Cas9, Gene Drive technology had two major setbacks restricting its success –
1) it is hard to achieve precise, desired changes in the genome; and 2) after eventually making
the desired change, the problem remains as to how to spread these changes quickly into the wild
16

population without having to release very high numbers of modified individuals into the wild
population to have desired impact (“The bold plan to end malaria with a gene drive” 2018).
Likewise, CRISPR-Cas9 technology is able to achieve precise changes in the genome and any
changes made are self-propagating (able to replicate itself into every proceeding generation), but
with no means to pushing these precise changes throughout the wild population without having
to release very large numbers of edited individuals into the environment. However, combining
the two technologies allow scientists to now have both the ability to make precise changes in the
genome of almost all sexually reproducing organisms and an effective means of pushing those
changes into a population. This is achieved through CRISPR-Cas9 enabled Gene Drive
technology. The technology practically addressed the setbacks of both technologies, Gene Drive
and CRISPR-Cas9, making it a very powerful tool in the genome editing technology.
CRISPR-Cas9 Enabled Gene Drive Approach
The CRISPR-Cas (clustered regularly interspaced short palindromic repeats (CRISPR) and
CRISPR-associated protein (Cas)) system is an adaptive immune system of bacteria and archaea
that protects them against invading viruses (Bortesi and Fischer 2015). In the most recent years,
CRISPR-Cas9 has emerged as the newest gene editing technology and as a powerful tool in the
biotechnology industries, leading to numerous research work being currently conducted to
explore its potential uses in insect pest management for Agricultural insects, plant protection and
management of the insects that carry/transmit diseases to human. The CRISPR-Cas9 system is
essentially a tool to improve the effectiveness of Gene Drives.
CRISPRs had first been described in 1987 by Japanese researchers as a series of short direct
repeats interspaced with short sequences in the genome of Escherichia coli (E. coli) (Ishino et al.
17

1987 as cited in Doudna and Charpentier 2014). In the mid-2000s, a few laboratories began
investigating CRISPRs and CRISPRs were later detected in numerous bacteria and archaea
(Mojica et al. 2000 as cited in Doudna and Charpentier 2014). Before CRISPR-Cas became well
known (prior to 2013), artificially engineered hybrid enzymes – zinc-finger nucleases (ZFNs)
and transcription activator-like effector nucleases (TALENs), were the earlier tools for genome
editing. Using these gene editing tools, scientists could target specific genomic sites to be altered
(Bortesi and Fischer 2015, Enzmann 2018). Even though ZFN and TALEN methods enable the
site-specific insertion of gene drives, they still have significant setbacks that prevent them from
being widely adopted. ZFNs has limited target sites, is expensive and difficult to assemble (Lei
et al. 2016). TALENs were easier than ZFNs to produce and validate according to Doudna and
Charpentier (2014). However, difficulties of protein design, synthesis, and validation also
remained as a barrier to its widespread adoption. CRISPR-Cas9 system has shown to be more
efficient and less time-consuming compared with ZFNs or TALENs (Kumar and Jain 2014).
The CRISPR-Cas9 system presents a faster, cheaper and more efficient means for genome
editing – the system allows scientists to insert, delete, replace or regulate genes in many different
species, generating heritable, targeted mutations with precision that was previously not possible
(“FAQ: Gene Drives” n.d; Ricroch et al. 2017). One of the main practical advantages of
CRISPR-Cas technology compared to ZFNs and TALENs is the ease of multiplexing, which is
the simultaneous introduction of double-stranded breaks (DSBs) at multiple sites in the genome
that can be used to edit several genes at the same time (Li et al. 2013 as cited in Bortesi and
Fischer 2015).

IV. CRISPR-Cas9 Mechanisms and Methods for Delivery into the organism

18

In bacteria, the CRISPR system is triggered after the bacterium detects the presence of virus
DNA, and as part of the immune system response, guide-RNA molecules are produced to contain
sequencing that matches the DNA sequence of the invading virus. The matching sequence is
generated by obtaining a small piece of the invading virus’s DNA to build the matching RNAs
(like in the immunization process), then the guide-RNAs form a compound with the Cas9 protein
(endonuclease enzyme) (Genome Editing with CRISPR-Cas9 2014). The guide-RNA and the
Cas9 protein are the two main components of the CRISPR-Cas9 system – the two elements work
together to form the DNA case, which can copy and paste itself into a specific position (the
target site) within the genome (Courtier‐Orgogozo et al. 2017). Cas9 protein is a scissor-like
protein, sometimes referred to as molecular-scissors, whose job is to cut the DNA; guide-RNAs
are molecules responsible for guiding the Cas9 to a specific site in the genome where the cut
should be made, to cut out the old code and place in the new. CRISPR-Cas9 system is referred
by some as a sophisticated biological “search/replace” system (“What's a Gene Drive?” 2015).
Note that, as part of bacterial immune system, once the CRISPR cuts the matching sequence in
the virus DNA, the virus will die, but in a eukaryotic cell, once a DNA is damaged, the cell
repair is activated to repair the damage (Doudna 2017).
CRISPR-Cas9 genome editing is carried out when the Cas9 and the especially designed guideRNA molecules complex together and run/scan along the strands of DNA, in the genome of an
organism, seeking out matching sequences of genetic code using guide-RNA as a template
(“What's a Gene Drive?” 2015). Once the spot where the guide-RNA match is found, the guideRNA inserts between the two strands of the double-helix and rips them apart (creating the
double-strand break), which triggers the release of the Cas9 protein to initiate the cut, precisely
in that location, cutting out the double stranded helix on both sides of the DNA (“What's a Gene
19

Drive?” 2015). Once this happens to a cell, the cell’s natural response is to initiate cell repair.
The cell repair process has two repair pathways to repair a damaged DNA (non-homologous end
joining (NHEJ) and the homologous recombination (HR) repair pathways). In the nonhomologous end joining repair pathway, the cell essentially just grabs the two broken ends of the
DNA and essentially saws them back together (Jorgensen 2016). During the cell repair process is
where the CRISPR-Cas9 system is used to interfere with the process trough homologous
recombination (HR) repair pathway. In the homologous recombination (HR) repair pathway,
after the cut is made to the matching sequence in the DNA, the cell repairs the cut by using the
chromosome containing the drive cassette (guide-RNA, Cas9 enzymes and the altered gene) as a
template; as a result, the drive-containing chromosome is successfully copied into the
homologous wild-type chromosome (the damaged chromosome), completely replacing the wildtype DNA sequence at that position of the genome (Enzmann 2018) and consequently turning
any heterozygous into homozygous.
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Fig. 3: CRISPR /Cas9 Gene Editing Mechanism (ZeClinics n.d.).
Image source: Nature News: Carl Zimmer.

The method relies on the fact that double-strand breaks are most frequently repaired by the
homologous recombination (HR) repair pathway, (in the presence of a homologous DNA
template), rather than the non-homologous end joining (NHEJ) pathway (Heyer et al. 2010),
which is one of the limitations of the CRISPRS-Cas9 system that will be discussed later in this
review. Also, the copying of the drive allele into wild-type chromosomes will only occur if the
cell uses the homology-directed repair pathway to repair the double-strand break (Enzmann
2018). In addition, the homologous recombination (HR) repair pathway is the most suitable
repair process scientists can adopt because of the homology in both ends of the broken cell and
difference at the center – scientists can feed the center with the altered/desired piece of DNA
21

(Jorgensen 2016), creating desired mutations and other complex alterations, bypassing the
mechanisms of natural evolution, and producing the desired DNA sequence that will be inherited
by succeeding generations.
What makes the CRISPR-Cas9 mediated Gene Drive so efficient? In nature, one gene usually
has many different versions of itself, thus when parents with different versions of a gene pass on
their DNA to their offspring, each version gets inherited by only half of the offspring (Empinado
2015). In the CRISPR-Cas9 enabled Gene Drive process, the guide-RNA-Cas9 molecules allow
the drive cassette to continue the “search/replace” activity within the genome until all versions of
the target gene (wild-type versions of the gene) are identified and altered. This ensures that when
a CRISPR-Cas9 altered organism mates with the wild-type/unaltered organism, of the same
species, theoretically all its offspring will inherit the altered gene along with the CRISPR code
(the guide-RNA-Cas9) that enable precise changes at the desired sites in the genome, ensuring
that the desired alterations are passed on to every future generations (“What's a Gene Drive?”
2015). Researchers suggest that in theory, the release of just a few individuals within a
population could lead to complete invasion of the Gene Drive cassette within 15–20 generations
(Burt 2003 as cited in Courtier‐Orgogozo et al. 2017).
Method of Delivery into the Organism
For a given application, scientists must choose adapted delivery methods and strategies to fulfill
their objectives. For Agricultural applications, conventional Agrobacterium-mediated
transformation using plasmid vectors containing Cas9 and guide-RNA is mainly used to deliver
the CRISPR-Cas9 system into plants (Ricroch et al. 2017). The currently used delivery methods
for delivery into insects include microinjections of Gene Drives into the eggs or embryos of the
22

target insect species. Research is still underway to identify more efficient delivery methods of
the CRISPR-Cas9 system into the organisms.

V. CRISPR-Cas9 Applications in Agriculture and Medicine – for Insect Pest
Management and Crop Protection
CRISPR-Cas9 can be used in numerous applications in Agriculture and the medical fields for
management of insect pest and for crop protection. CRISPR-Cas9 technology can be used to
build drives, for example, to block harmful pest behaviors, like swarming of Locusta migratoria,
migratory locus (Orthoptera: Acrididae) and to sensitize pests – to make them susceptible to
specific compounds, like insecticides. Drives can be built to alter or eradicate vector-born
insects, and even to eventually learn how to reprogram olfaction in insects to discourage crop
consumption or to make mosquitoes dislike the way we smell (Esvelt 2015).
Agricultural Applications
One of the first reported application of the CRISPR-Cas9 system in insects was carried out in
Drosophila, fruit flies (Diptera: Drosophilidae), in which mutations were successfully introduced
to the yellow gene (Gratz et al. 2013 as cited in Lei et al. 2016). Another successful application
of the system in Bombyx mori, Silkworm (Lepidoptera: Bombycidae), was reported, where
BmBLOS2 gene was targeted (Wang et al. 2013 as cited in Lei et al. 2016), followed by other
successful applications.
In a case study by Garczynski et al. (2017), CRISPR-Cas9 gene editing system was used to edit
the genome of Cydia pomonella, Codling Moth (Lepidoptera: Tortricidae), targeting a specific
gene (CpomOR1) to affect egg production and viability. Codling moth is a major, global pest of
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pome fruit. The CpomOR1 gene is an odorant receptor belonging to the pheromone receptor
subfamily in codling moth. Single-guide RNAs (sgRNAs), targeting nucleotides of the
CpomOR1 gene, were built and injected into the early stage eggs of the codling moths.
Observations showed that mutations were successfully introduced, including both deletions and
insertions (Garczynski et al. 2017). The study reared emerging neonates to adulthood, and
attempted to create stable populations of edited codling moths by mating males with females
carrying mutations of the CpomOR1 gene. Results showed that fecundity and fertility were
affected, resulting in edited females producing nonviable eggs. However, the exact role of
CpomOR1 in fecundity and fertility in codling moths is currently not exactly understood.
In another case, the CRISPR-Cas9 system was used to induce a targeted heritable mutagenesis of
the migratory locust. Locusts are important Agricultural pests worldwide, and their swarming
behavior can cause damages to crops over wide areas at a time, often resulting in serious
economic implications. In a study by Li et al. (2016), a target sequence of guide-RNA was
designed to disrupt the gene encoding of the odorant receptor co-receptor (Orco). The authors
then examined the roles of the odorant receptor pathway in the locust. Observations
demonstrated an efficient target-gene editing, resulting in Orco gene mutants to show impaired
electrophysiological responses to multiple odors, which resulted in mutant locusts to lose an
attraction response to aggregation pheromones under the crowding conditions (Li et al. 2016).
For crop protection, CRISPR-Cas9 systems can be used to give crops enhanced tolerance to
certain stressors (biotic and abiotic) and enhance plant quality. We know that many insects are
attracted to unhealthy, diseased plants, thus maintaining good plant health is part of an Integrated
Pest Management program. CRISPR-Cas9 systems can be used to edit plants such that the plant
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emits or does not emit specific enzymes that can deter insect pests from contacting the plant or
attracting certain insect predators to prey on the insect species that are attacking the plant.
To achieve plant viral disease resistance, for example, one of the strategies is to integrate the
CRISPR-coding sequence into the host plant’s genome to target and interfere with the virus
genome once the plant is infected, acting as a CRISPR-like immune system in the genome of the
host (Shen et al. 2018; Xu et al. 2016 as cited in Ricroch et al. 2017). According to Ji et al.
(2015), a transient assay performed in Nicotiana benthamiana (Tobacco plant) using a CRISPRCas-based approach demonstrated resistance to the Gemini virus, beet severe curly top virus.
CRISPR-Cas9 systems can also be used in conjunction with transgenic technology to engineer
crops that are resistant to many other plant diseases – this can be achieved through molecular
breeding technology. For example, if we have a corn variety with a good yield potential (Fig. 4.
Plant B) but this variety is also very susceptible to a plant disease, we can use CRISPR-Cas9
technology to engineer a guide-RNA with the resistance gene (from plant A) (Fig. 4. Plant A)
and send it to find the susceptible gene in the genome of plant B, have the Cas9 cut out the
susceptible gene and replace it with the resistance gene to obtain the desired corn variety (Fig. 4.
plant C) (“CRISPR-Cas in Agriculture” 2017).
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Fig. 4: CRISPR/Cas9 Mediated Transgenic Corn. Plant Image Source: National Press Foundation.

Applications for Managing Pests of Medical Importance
There are several opportunities for using CRISPR-Cas9 enabled gene editing techniques for
effective management of insects that carry/transmit diseases to human and/or domestic animals.
The technique can be used to eradicate vector-borne diseases (malaria, dengue, Lyme disease
West Nile virus, Zika Virus and other vector-borne diseases). Vectors can be altered to prevent
them from carrying and transmitting diseases or directly eradicating their population.
CRISPR-Cas9 systems targeting female reproduction in the Anopheles gambiae, malaria
mosquito vector (Diptera: Culicidae) was studied by Hammond et al. (2016). The team identified
three genes (AGAP005958, AGAP011377 and AGAP007280) that are responsible for a
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recessive female sterility in the Anopheles gambiae mosquitoes. CRISPR-Cas9 Gene Drive was
designed to target and edit each of the genes. For each targeted locus, a strong Gene Drive was
observed at the molecular level with transmission rates to progeny of 91.4 to 99.6% (Hammond
et al. 2016). Additionally, the study showed that a CRISPR-Cas9 system targeting one of these
loci, AGAP007280, meets the minimum requirement for a Gene Drive targeting female
reproduction in an insect population. In another study by Gantz et al. (2015), the CRISPR-Cas9
system was developed to target Plasmodium falciparum, the human malaria parasite, in
Anopheles stephensi, Asian malaria vector mosquitoes (Diptera: Culicidae), and successfully
inactivating genes required for malaria parasite growth.
Other controlled studies using the CRISPR-Cas9 system to target Aedes aegypti, the yellow fever
mosquito (Diptera: Culicidae), were completed to explore new ways to interrupt the viral disease
cycles. The yellow fever mosquito is the primary vector for arboviruses that cause yellow fever,
dengue, and chikungunya, which cause significant mortality and illnesses among people living in
tropical regions of the world (Dong et al. 2015). A study by Kistler et al. (2015) showed that
CRISPR-Cas9 can be used to engineer precise “loss-of-function” mutations, allowing for
detailed genetic study of yellow fever mosquito vector. This offers scientists the knowledge of
possible CRISPR-Cas9 applicability in genome modifications (Kistler et al. 2015).
Species-oriented population suppressions can be achieved using CRISPR-Cas9 systems to build
and deliver deleterious Gene Drives to make genetic changes that will essentially cause the
population to crash, or creating Gene Drives to bias population towards one sex (McFarlane et al.
2018). If the Gene Drive eliminates a female-specific, or male-specific genes essential for
reproduction, for example, this can in theory lead to extinction of the specie (Burt 2003 as cited
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in Courtier‐Orgogozo et al. 2017). Other more complex alterations that can be achieved through
CRISPR-Cas9 enabled Gene Drive systems include the possibility of making a population be
uniquely vulnerable to otherwise harmless compounds (sensitize the population), thus allowing
the development of species-specific insecticides for example. Another potential alteration
includes splitting a population into reproductively incompatible groups (speciate the population)
(Esvelt 2015).
Eradication of vector-borne diseases (diseases spread by insects) has been a common focus of
gene drives, with special interest in developing a drive that could eradicate malaria, which is
caused by Plasmodium parasites and transmitted by Anopheles mosquitoes (Enzmann 2018).
Malaria kills hundreds of thousands of people each year in certain parts of the world. Researcher
groups have already developed and tested CRISPR-Cas9 gene drives to spread malaria-resistance
genes and drives to induce female sterility in the population of laboratory contained mosquitoes.
Reversibility – The CRISPR-Cas9 is a reversible system; this means if scientists edit a gene
using the CRISPR-Cas9 technology and later don’t like it, the change can be reversed by creating
another CRISPR-Cas9 Gene Drive to undo the change. Esvelt (2015) indicated that such reversal
has already been demonstrated in a lab experiment with yeast where the HN3 genes was spread
with Gene Drive through the lab yeast population and then a reversal Gene Drive was built that
successfully undid that particular change and restored the gene that had been broken. But it’s
important to note that the reversal will not undo any ecological changes that resulted from the
original edit (Esvelt 2015).
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VI. CRISPR-Cas9 Limitations
One of the main limiting factor of the CRISPR-Cas9 technology is the fact that scientists don’t
yet completely understand how cells work - for instance, it’s still unclear to scientists as to why
some guide-RNA work well and some don’t, or why some cells use one type of the repair
pathway over the other (Doudna 2015). Though, we know that the CRISPR-Cas9 system relies
more on the fact that cells use the homologous recombination (HR) repair pathway more
frequently to repair double-strand breaks, (in the presence a homologous DNA template) rather
than the non-homologous end joining (NHEJ) pathway. However, we don’t know why the cell
does this. Studies have shown that the frequency with which the cell chooses one repair pathway
vs. the other varies between organisms, cell types and between developmental stages of the
organisms (Esvelt 2015).
One of the most significant limitations of the CRISPR-Cas9 system is the appearance of certain
off-target effects, pointed out by Crauciuc et al. (2017), although in a small percentage compared
to previous techniques. Scientists need to understand better how to control the way DNA is
repaired after it’s been cut/broken and figure out how to control and limit any off-target or
unintended effects (Doudna 2015). Another limitation of the CRISPR-Cas9 system is the issue of
getting the system into the cell successfully (delivery method); the currently used methods are
still not very effective (Gantz and Akbari 2018).

VII. CRISPR-Cas9 Potential Issues and Concerns
Currently most of the research work on CRISPR-Cas9 mediated gene editing technology are
being conducted in the confinement of laboratories and have been shown to work in controlled
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populations of fruit flies, mosquitoes, yeast (Noble et al. 2018) and other species. But as
researchers are looking forward to applying the system into the environment, both the
researchers and the public have highlighted the potential issues we could face as the result of the
CRISPR-Cas9 Gene Drive system application into the environment.
To address such concerns, the World Health Organization (WHO) has outlined the steps that
gene-drive Genetically Modified (GM) mosquitoes should go through before being deployed into
the environment (“The bold plan to end malaria with a gene drive” 2018) – (Fig.5). Currently,
Gene Drive research is in phase 1.

Fig. 5: WHO Phased Testing Pathway. Image source: Vox (2018)

Ecological impacts – These have been at the center of most discussions concerning the potential
side effects of the CRISPR-Cas9 Gene Drive technology. The most discussed issue includes the
potential for Gene Drives disrupting the ecosystem and thus creating unforeseen risks to other
species, potentially including humans. This could happen through the mechanism of “geneflow,” which could potentially allow drives to move beyond their target population (Esvelt
2019). Another often debated issue about the use of the CRISPR-Cas9 technology in insect
management includes the concerns about potential consequences of eradicating mosquito
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species, for example. Though we don’t know of many real benefits mosquitoes provide to
humans or to the environment, but we know that bats and some fish species use mosquitoes as a
food source. Therefore, with the disappearance of mosquitoes, bats could be forced to find
alternate food sources, find different niches to occupy or be forced to share niches with another
species and potentially, indirectly affecting humans. Also, mosquitoes could be pollinators of
some plants that we don’t even know about until they disappear.
Another potential issue with the technology is the potential for the unexpected, undesired
mutations that can occur – a mutation could occur in the process, which has the potential to allow
in unwanted traits and therefore, potentially affecting other aspects of the ecology. Some offtarget mutations can result in cell death or transformation (Zhang et al. 2014).
Ethical issues – One of the most controversial ethical issues associated with CRISPR-Cas9
technology involves its application in human and animals’ reproductive cells. The United States
currently does not have a ban on human reproductive cell modification (Beale 2016), nor is it
regulated. However, many scientists have called for a pause on CRISPR-Cas9 work in human
and animals’ reproductive cells due to safety and ethical concerns (Beale 2016). In June 2016,
the United States National Academies of Sciences, Engineering, and Medicine released a report
on their recommendations for “Responsible Conduct" of Gene Drives (“Gene Drive Research in
Non-Human Organisms: Recommendations for Responsible Conduct" 2016).
Concerns have been raised over the relationships that may exist between the use of CRISPRCas9 gene editing methods and Genetically Modified Organisms (GMOs). In the U.S.A., the
legal status of CRISPR-Cas-induced mutations is that they are exempt from GMO laws (Ricroch
et al. 2017) since the changes that are made in the gene editing process are very often ones that
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could have occurred naturally without any genetic manipulations (Carroll 2017). This is unlike
transgenic technology, which refers to the transfer of genetic material from one organism to
another by means of genetic manipulation.
Many people fear that the current lack of regulations behind the CRISPR-Cas9 technology has
presented great potential for the misuse of the technology, especially in human cells, to
potentially design Gene Drives that will give genetically enhanced abilities (higher intelligence,
superior muscular development, resistance to certain illnesses etc.) to the future generations of
certain people. Or it could be misused to potentially create weaponized super mosquitoes
(“What's a Gene Drive?” 2015) or any other dangerous animal or unethical looking creatures.
Conversely, many argue that misuse of the CRISPR-Cas9 system would not necessarily be
productive, nor profitable, consequently discouraging its potential misuse. For instance, building
drives to create super intelligent people – this could be counterproductive (after all, studies have
shown that highly intelligent people are generally highly prone to depression).
Other ethical issues – Will it be fair for the mosquitoes, some ask. As far as we know,
mosquitoes do not benefit from carrying these pathogens and therefore, altering the mosquitoes
to not carry disease-causing pathogens will be fair, in the opinion of many. However, uses for the
eradication of the mosquito species can be trickier to consider. Some ask if malaria is bad
enough to risk it; some ask if it is ethnical to not do it, given that millions of people are dying
from malaria and other mosquito borne infections every year. Also, many wonder who exactly
will be in charge of making such decisions – is it the scientists, the governments or the
communities of those whom will be affected by the potential risks and/or benefits of the
practice? (“What's a Gene Drive?” 2015).
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VIII. Conclusion and Prospects
CRISPR-Cas9 enabled gene editing technology is still an emerging tool driving scientific efforts
in exploring its full potential. The technology offers revolutionary efficiency in the field of
genome editing. But before its full application for insect pest management or plant protection,
extensive knowledge of the genome and gene functionalities of the target species is required. The
application of the CRISPR-Cas9 gene editing system requires the precise definition of the target
DNA sequence and the availability of good genome sequence data of the studied species to allow
designs of single-guide RNAs (Ricroch et al. 2017). Understanding the homology-directed repair
mechanisms that follow Cas9-mediated DNA cleavage is also needed to enhance insertion of
new or corrected sequences into genomes (Doudna and Charpentier 2014).
The CRISPR-Cas9 system itself can be used as a tool to gain useful information about gene
functions as mediated by RNA. Gaining these knowledges will allow scientists to apply the
system with more precision, thus minimizing the off-target rate. In addition, further advances in
our understanding and control of the technology will likely lead to continued optimization of the
CRISPR-Cas9 technologies, allowing us to better understand and overcome potential limitations
and risks (Bortesi and Fischer 2015; Gantz and Akbari 2018). With no doubt, CRISPR-Cas9
gene editing technology holds great potential for a more effective and permanent insect pest
management.
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